Biologic activities of growth hormone secretagogues in humans (Q34231668)

2

1 reference

31 July 2017

Giordano R

3

1 reference

31 July 2017

Broglio F

4

1 reference

31 July 2017

Gianotti L

5

1 reference

31 July 2017

Maccario M

6

1 reference

31 July 2017

Bisi G

7

1 reference

31 July 2017

Graziani A

8

1 reference

31 July 2017

Papotti M

9

1 reference

31 July 2017

Muccioli G

10

1 reference

31 July 2017

Deghenghi R

11

1 reference

31 July 2017

Camanni F

https://scigraph.springernature.com/pub.10.1385/endo:14:1:087

12

1 reference

31 July 2017

1 February 2001

1 reference

31 July 2017

1 reference

31 July 2017

14

1 reference

31 July 2017

87-93

1 reference

31 July 2017

1

1 reference

31 July 2017

0 references

cites work

The GH-releasing effect of Hexarelin, a synthetic hexapeptide, in newborns is lower than in young adults

1 reference

12 December 2020

Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma

1 reference

12 December 2020

Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans.

1 reference

12 December 2020

Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats.

1 reference

12 December 2020

Growth hormone-releasing peptides

1 reference

12 December 2020

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.

1 reference

12 December 2020

Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before and during puberty

1 reference

12 December 2020

Metabolic modulation of the growth hormone-releasing activity of hexarelin in man.

1 reference

12 December 2020

Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome

1 reference

12 December 2020

Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors

1 reference

12 December 2020

The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids.

1 reference

12 December 2020

Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release.

1 reference

12 December 2020

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

12 December 2020

The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis.

1 reference

12 December 2020

Cardiac effects of hexarelin in hypopituitary adults

1 reference

12 December 2020

Oestrogen replacement does not restore the reduced GH-releasing activity of Hexarelin, a synthetic hexapeptide, in post-menopausal women.

1 reference

12 December 2020

The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction.

1 reference

12 December 2020

Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man

1 reference

12 December 2020

Influence of galanin and serotonin on the endocrine response to Hexarelin, a synthetic peptidyl GH-secretagogue, in normal women

1 reference

12 December 2020

Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans

1 reference

12 December 2020

Binding sites for growth hormone-releasing peptide

1 reference

12 December 2020

Widespread transcription of the growth hormone-releasing peptide receptor gene in neuroendocrine human tumors

1 reference

12 December 2020

Modulation of growth hormone-releasing activity of hexarelin in man

1 reference

12 December 2020

Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat.

1 reference

12 December 2020

Hexarelin exhibits protective activity against cardiac ischaemia in hearts from growth hormone-deficient rats.

1 reference

12 December 2020

Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin

1 reference

12 December 2020

Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans

1 reference

12 December 2020

Growth hormone-releasing peptide and its analogues Novel stimuli to growth hormone release

1 reference

12 December 2020

Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans

1 reference

12 December 2020

Intracerebroventricular growth-hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in rats

1 reference

12 December 2020

A receptor in pituitary and hypothalamus that functions in growth hormone release

1 reference

12 December 2020

Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man.

1 reference

12 December 2020

Ipamorelin, the first selective growth hormone secretagogue

1 reference

12 December 2020

Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients

1 reference

12 December 2020

Peptidomimetic regulation of growth hormone secretion

1 reference

12 December 2020

Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection

1 reference

12 December 2020

Growth hormone-releasing hormone receptor (GHRH-R) and growth hormone secretagogue receptor (GHS-R) mRNA levels during postnatal development in male and female rats.

1 reference

12 December 2020

Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.

1 reference

12 December 2020

Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation

1 reference

12 December 2020

The effect of an opiate antagonist on the hormonal changes induced by hexarelin

1 reference

12 December 2020

Corticotropin-releasing hormone in humans

1 reference

12 December 2020

Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585.

1 reference

12 December 2020

Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hyp

1 reference

12 December 2020

Growth hormone secretagogues as corticotrophin-releasing factors

1 reference

12 December 2020

Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labeling

1 reference

12 December 2020

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.

1 reference

12 December 2020

Human aging and the GH-IGF-I axis.

1 reference

12 December 2020

Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide

1 reference

12 December 2020

Hexarelin induced growth hormone release is influenced by exogenous growth hormone

1 reference

12 December 2020

The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations

1 reference

12 December 2020

Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.

1 reference

12 December 2020

Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue.

1 reference

12 December 2020

Identification and characterization of a new growth hormone-releasing peptide receptor in the heart

1 reference

12 December 2020

Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man.

1 reference

12 December 2020

Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies.

1 reference

12 December 2020

Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency

1 reference

12 December 2020

Corticotropin-Releasing Effect of Hexarelin, a Peptidyl GH Secretagogue, in Normal Subjects Pretreated with Metyrapone or RU-486, a Glucocorticoid Receptor Antagonist, and in Patients with Addison’s Disease

1 reference

12 December 2020

Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP-6

1 reference

12 December 2020

Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man.

1 reference

12 December 2020

Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects

1 reference

12 December 2020

1 reference

12 December 2020

Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues

1 reference

12 December 2020

Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland.

1 reference

12 December 2020

Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6.

1 reference

12 December 2020

Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans

1 reference

12 December 2020

Human fetal pituitary expresses functional growth hormone-releasing peptide receptors

1 reference

12 December 2020

Preserved growth hormone (GH) secretion in aged and very old subjects after testing with the combined stimulus GH-releasing hormone plus GH-releasing hexapeptide-6.

1 reference

12 December 2020

The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.

1 reference

12 December 2020

Growth Hormone Secretagogues: Physiological Role and Clinical Utility

1 reference

12 December 2020

Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man

1 reference

12 December 2020

Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors

1 reference

12 December 2020

Interaction of the growth hormone releasing peptide hexarelin with somatostatin

1 reference

12 December 2020

Growth hormone-independent cardioprotective effects of hexarelin in the rat

1 reference

12 December 2020

Peptidomimetic Regulation of Growth Hormone Secretion

1 reference

12 December 2020